Zobrazeno 1 - 10
of 324
pro vyhledávání: '"Yoshiaki Tomiyama"'
Autor:
Drew Provan, Donald M. Arnold, James B. Bussel, Beng H. Chong, Nichola Cooper, Terry Gernsheimer, Waleed Ghanima, Bertrand Godeau, Tomás José González-López, John Grainger, Ming Hou, Caroline Kruse, Vickie McDonald, Marc Michel, Adrian C. Newland, Sue Pavord, Francesco Rodeghiero, Marie Scully, Yoshiaki Tomiyama, Raymond S. Wong, Francesco Zaja, David J. Kuter
Publikováno v:
Blood Advances, Vol 3, Iss 22, Pp 3780-3817 (2019)
Abstract: Over the last decade, there have been numerous developments and changes in treatment practices for the management of patients with immune thrombocytopenia (ITP). This article is an update of the International Consensus Report published in 2
Externí odkaz:
https://doaj.org/article/615595aac465412eafebf2c7540a0966
Autor:
Yukihiro Nishikawa, Shiyo Nishida, Keiko Kuroda, Hirokazu Kashiwagi, Yoshiaki Tomiyama, Masataka Kuwana
Publikováno v:
Diagnostics, Vol 12, Iss 2, p 313 (2022)
Plasma thrombopoietin (TPO) measurements help distinguish between different types of thrombocytopenia but are not feasible in routine clinical practice. We developed a fully automated quantitative chemiluminescent enzyme immunoassay (CLEIA) for measu
Externí odkaz:
https://doaj.org/article/0980dbe6d4d841eb92340f4ff34b44ae
Autor:
Shigenori Honda, Hiroko Shirotani-Ikejima, Seiji Tadokoro, Yoshiaki Tomiyama, Toshiyuki Miyata
Publikováno v:
PLoS ONE, Vol 8, Iss 12, p e85498 (2013)
Integrin-linked kinase (ILK) is an important signaling regulator that assembles into the heteroternary complex with adaptor proteins PINCH and parvin (termed the IPP complex). We recently reported that ILK is important for integrin activation in a Ch
Externí odkaz:
https://doaj.org/article/9eee5e8aa5c046aa8afba6fb6384bfc9
Autor:
Kinuko Mitani, Jong Wook Lee, Jun Ho Jang, Yoshiaki Tomiyama, Koji Miyazaki, Koji Nagafuji, Kensuke Usuki, Nobuhiko Uoshima, Tomoaki Fujisaki, Hiroshi Kosugi, Itaru Matsumura, Ko Sasaki, Masahiro Kizaki, Masashi Sawa, Michihiro Hidaka, Naoki Kobayashi, Satoshi Ichikawa, Yuji Yonemura, Kenta Murotani, Mami Shimizu, Akira Matsuda, Keiya Ozawa, Shinji Nakao
Publikováno v:
Blood. 140:8634-8637
Autor:
Masayuki Kubo, Kazuya Sakai, Masaki Hayakawa, Hirokazu Kashiwagi, Hideo Yagi, Yoshinobu Seki, Atsushi Hasegawa, Haruyuki Tanaka, Itsuto Amano, Yoshiaki Tomiyama, Masanori Matsumoto
Publikováno v:
Journal of Thrombosis and Haemostasis. 20:1589-1598
Patients with essential thrombocythemia (ET) often experience bleeding associated with acquired von Willebrand syndrome (AVWS) when the platelet count is markedly increased.We investigated whether von Willebrand factor (VWF) degradation is enhanced i
Autor:
Mika Hosokawa, Keisuke Nagamine, Hiroshi Aochi, Kotarosumitomo Nakayama, Mikiko Sakuragi, Tamayo Morikawa, Mayumi Nakao, Tomoko Kiyokawa, Hisashi Kato, Yoshiaki Tomiyama, Hirokazu Kashiwagi
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 68:412-421
Autor:
Mayumi Nakao, Hiroshi Aochi, Kotarosumitomo Nakayama, Mika Hosokawa, Mikiko Sakuragi, Tamayo Morikawa, Tomoko Kiyokawa, Keisuke Nagamine, Hisashi Kato, Hirokazu Kashiwagi, Yoshiaki Tomiyama
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 68:28-33
Autor:
Keigo Akuta, Kentaro Fukushima, Keiichi Nakata, Satoru Hayashi, Jun Toda, Yasuhiro Shingai, Kazuhito Tsutsumi, Tomohisa Machida, Akihisa Hino, Shinsuke Kusakabe, Yukiko Doi, Jiro Fujita, Hisashi Kato, Tetsuo Maeda, Takafumi Yokota, Yoshiaki Tomiyama, Naoki Hosen, Hirokazu Kashiwagi
Publikováno v:
International Journal of Hematology. 115:322-328
Autoimmune hematological disorders are rare complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Diagnosis of immune thrombocytopenia (ITP) is challenging, especially after allo-HSCT, because various complications such
Autor:
Tomoko Kiyokawa, Kazuya Mimura, Keisuke Nagamine, Kotarosumitomo Nakayama, Mikiko Horiuchi, Tamayo Morikawa, Mika Hosokawa, Mayumi Nakao, Masayuki Endo, Tadashi Kimura, Hisashi Kato, Yoshiaki Tomiyama, Hirokazu Kashiwagi
Publikováno v:
International Journal of Hematology.
Autor:
Masataka, Kuwana, Tomoki, Ito, Shugo, Kowata, Yoshihiro, Hatta, Katsumichi, Fujimaki, Kensuke, Naito, Shingo, Kurahashi, Toshiya, Kagoo, Kazuki, Tanimoto, So, Saotome, Yoshiaki, Tomiyama, Tomofumi, Yano
Publikováno v:
British journal of haematologyREFERENCES.
Fostamatinib, a spleen tyrosine kinase inhibitor, has been approved for the treatment of chronic primary immune thrombocytopenia (ITP) in the United States, Canada and some European countries. We conducted a phase 3, placebo-controlled, double-blind,